Mark Bloch
- Virology top 0.5%
- HIV Research and Treatment 26
- Infectious Diseases top 1%
- HIV/AIDS Research and Interventions 30
- HIV/AIDS drug development and treatment 27
- Emergency Medicine top 1%
- HIV-related health complications and treatments 18
- Hepatology top 10%
- Hepatitis C virus research 10
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
- HIV, Drug Use, Sexual Risk 6
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Roy G. D’AndradeDon SmithDavid A. CooperSherene MinRobert FinlaysonFrançois RaffiAnita RachlisJohn Zaunders
- Journals
- AIDS (7 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (4 papers)HIV Medicine (4 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Bloch
56 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Virology 1.0k
- Infectious Diseases 1.2k
- Emergency Medicine 454
- Experimental and Cognitive Psychology 195
- Hepatology 82
Countries citing papers authored by Mark Bloch
This map shows the geographic impact of Mark Bloch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bloch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bloch more than expected).
Fields of papers citing papers by Mark Bloch
This network shows the impact of papers produced by Mark Bloch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bloch. The network helps show where Mark Bloch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Bloch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 9 | |
| 5 | 2020 | 3 | |
| 6 | 2018 | 28 | |
| 7 | 2017 | 25 | |
| 8 | 2017 | 61 | |
| 9 | 2017 | 37 | |
| 10 | 2015 | 27 | |
| 11 | 2014 | 4 | |
| 12 | Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 studybreakdown → | 2013 | 404 |
| 13 | 2013 | 46 | |
| 14 | 2011 | 32 | |
| 15 | 2011 | 1 | |
| 16 | 2005 | 46 | |
| 17 | 2005 | 80 | |
| 18 | 2002 | 137 | |
| 19 | 2000 | 3 | |
| 20 | 1999 | 11 |
About Mark Bloch
Mark Bloch is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 58 papers that have together received 2.3k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (30 papers), HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (26 papers), HIV-related health complications and treatments (18 papers), Hepatitis C virus research (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), HIV, Drug Use, Sexual Risk (6 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (1.2k citations) and Emergency Medicine (454 citations). Mark Bloch has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Roy G. D’Andrade, Don Smith, David A. Cooper, Sherene Min, Robert Finlayson, François Raffi, Anita Rachlis, John Zaunders, Chloe Orkin and W. D. Hardy. Their work appears in journals such as AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, HIV Medicine, Journal of Hepatology and HIV Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.